Clinical Trials @ RGW

bars-index-header-blue-1
bars-index-header-orange

Clinical Trials @ RGW

Clinical Research

Please contact your provider to learn if you are eligible for any of our enrolling clinical trials.  

Benefits to participants

    • Learn more about your eye condition
    • Receive free study-related eye examinations, when appropriate
    • Help others by assisting researchers to find better and more effective treatments
    • Receive possible financial compensation for your time


The Retina Group of Washington is currently enrolling patients for the following major Clinical Trials (diseases in parentheses):


Fairfax, VA

Alexion- Danicopan (Geographic Atrophy Secondary to Age-Related Macular Degeneration)
Coast – OPT-302 with Aflibercept (Neovascular Age-related Macular Degeneration)
Notal Vision Home OCT Study – Evaluation of Repeated, In Clinic, Self-Imaging (Diabetic Macular Edema)

Chevy Chase, MD

Parasol/ Janssen- JNJ-81201887 Compared to Sham (Geographic Atrophy Secondary to Age-related Macular Degeneration) 


The Retina Group of Washington is currently actively participating but no longer enrolling in the following major Clinical Trials (diseases in parenthesis):

Chevy Chase, MD

“Opthea Shore Study – Treatment naïve wet AMD Lucentis and OPT”
“Janssen Parasol – Treatment naïve Geographic Atrophy”

Sub-Studies
Ulcerative Colitis (Capital Digestive) 

Fairfax, VA

“Apellis Garland – Syfovre for Dry AMD/Geographic Atrophy”
“Opthea Coast – Treatment naïve wet AMD Eylea and OPT”

Sub-Studies
Next Oncology
Virginia Cancer Specialists

Loading ...

©All Rights Reserved. RGW 2024